Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;23(12):4307-4313.
doi: 10.31557/APJCP.2022.23.12.4307.

Awareness about Human Papillomavirus Vaccine and Its Uptake among Women from North India: Evidence from a Cross-Sectional Study

Ataur Rehman  1 , Shobhit Srivastava  1 , Priyanka Rani Garg  1 , Rishi Garg  1 , Kauma Kurian  1 , Shumayla Shumayla  1 , Suresh Kumar Rathi  2 , Sunil Mehra  1
Affiliations

Awareness about Human Papillomavirus Vaccine and Its Uptake among Women from North India: Evidence from a Cross-Sectional Study

Ataur Rehman et al. Asian Pac J Cancer Prev. .

Abstract

Objective: This study aims to estimate the prevalence of human papillomavirus (HPV) vaccine usage and determine the factors for awareness about HPV vaccine among women in reproductive age group.

Methods: This is a cross-sectional survey under a cervical cancer prevention study. The sample size was 1020 women, aged 15-49 years [550 in Delhi and 470 in Rohtak]. Bivariate analysis and Fisher exact test along with binary logistic regression analysis were used to determine the factors for awareness.

Result: About 18.0 % [Delhi: 24.2 % and Rohtak: 10.9 %] of the respondents had heard about the vaccine against cervical cancer. The women aged more than 30 years [AOR: 1.35; CI: 0.94, 1.94] were more likely to be aware of cervical cancer vaccine as compare to women of 30 years and less. However, the women from Rohtak [AOR: 0.90; CI: 0.48, 1.66] were less likely to be aware of vaccine against cervical cancer in reference to women aged 30 years and more [AOR: 1.61; CI: 1.01, 2.56] from Delhi. About 0.6 % [Delhi: 1.1 % and Rohtak: 0.0 %] of the respondents had received HPV vaccine.

Conclusion: Women tend to have limited knowledge about cervical cancer vaccine and immunisation practices. The women's demographic makeup varied significantly between the two sites, i.e , Rohtak and Delhi, which had an impact on how well they understood and utilised the cervical cancer vaccination. It is worth mentioning that none of the women from Rohtak had received the immunisation. The awareness of the cervical cancer vaccine among women from the Rohtak was lower than the Delhi women.

Keywords: Cervical cancer; Human Papillomavirus Vaccines; Vaccination; Vaccine Awareness, India.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to disclose.

Similar articles

See all similar articles

Cited by

References

    1. Beavis AL, Levinson KL. Preventing cervical cancer in the United States: Barriers and resolutions for HPV vaccination. Front Oncol. 2016;6:1–9. - PMC - PubMed
    1. Bosch FX, de Sanjosé S. Human Papillomavirus and Cervical Cancer—Burden and Assessment of Causality. JNCI Monographs. 2003;31:3–13. - PubMed
    1. Bruni L, Serrano B, Roura E et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob. Health. 2022;10:e1115–e1127. - PMC - PubMed
    1. Endarti D, Satibi , Kristina SA et al. Knowledge, Perception and Acceptance of HPV Vaccination and Screening for Cervical Cancer among Women in Yogyakarta Province, Indonesia. Asian Pac J Cancer Prev. 2018;19:1105–11. - PMC - PubMed
    1. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities. PLoS Med. 2008;5:e132. - PMC - PubMed